National Oesophago-Gastric Cancer Audit, 2017

Making clinical audit data transparent. In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Oesophago-Gastric Cancer Audit covers the quality of care given to patients with Oesophago-Gastric (OG) cancer. The audit evaluates the process of care and the outcomes of treatment for all OG cancer patients, both curative and palliative. From April 2012, the audit has been extended to include patients with Oesophageal High-Grade Dysplasia (HGD). The National Oesophago-gastric Cancer Audit is a high profile, collaborative, national clinical audit for oesophago-gastric cancer run jointly by NHS Digital, The Association of Upper Gastrointestinal Surgeons of Great Britain & Ireland (AUGIS), British Society of Gastroenterologists (BSG) and The Clinical Effectiveness Unit at the Royal College of Surgeons of England. The audit aims to improve the quality of care and survival of patients with oesophago-gastric cancer. It meets the requirements as set out in the NHS Cancer Plan and NICE guidelines. Accessing the data The data are being made available on the data.gov website. Each year files of data from the National Oesophago-Gastric Cancer Audit will be made available in CSV format. Trusts and Cancer Alliances are identified by name and organisation code. What does the data cover? The data measures levels of completeness for data submitted to the National Oesophago-Gastric Cancer Audit and measures of performance and participation in the audit at trust level for key performance measures. Further details of these can be found in the annexes of the National Oesophago-Gastric Cancer Audit Report 2017. •Audit participation by NHS Trust and data completeness for the key fields. •Measures about the process of care given to patients. •Information about care outcomes and treatment. These data do not list individual patient information, nor do they contain any patient identifiable data. Are all Trusts included? All Trusts in England and Wales that manage patients diagnosed with oesophago-gastric cancer are included. What period does the data cover? The National Oesophago-gastric Cancer Audit 2016 covers the time period from 1st April 2013 to 31st March 2016 (with some measures restricted to the period 1st April 2014 to 31st March 2016) for people diagnosed with oesophago-gastric cancer and from 1st April 2012 to 31st March 2016 for patients with high grade dysplasia, including hospital sites within England and Wales.